Organ-specific expression of IGF-I during early development of bony fish as revealed in the tilapia, Oreochromis niloticus, by in situ hybridization and immunohistochemistry: indication for the particular importance of local IGF-I Abstract The cellular sites of insulin-like growth factor
Introduction
Autocrine, paracrine and endocrine signals co-ordinate the direction of differentiation of tissues during critical periods of development. The differentiation of organs thus involves a complex cascade and interaction of signals whose organizational action on tissue differentiation is dependent on being released at precise times, at correct sites (in the case of para-and autocrine factors) and within a specific dose range (Segner et al. 1994 ). Insulin-like growth factor I (IGF-I) plays a central role in the complex system that regulates growth, differentiation and reproduction (see review: Reinecke and Collet 1998) .
As in mammals, the major site of IGF-I gene expression in bony fish is liver but several extrahepatic sites also express IGF-I (for reviews, see Reinecke and Collet 1998; Duan 1998; Reinecke et al. 2005; Wood et al. 2005) . Recently, by the use of real-time reverse transcription/ polymerase chain reaction (RT-PCR), the absolute amounts of IGF-I have been measured in adult tilapia, Oreochromis niloticus (Caelers et al. 2004) , and significant levels of IGF-I mRNA have been measured not only in liver, but also in other organs, such as brain, gills, heart, intestine, kidney, skeletal muscle, spleen and testes. These results are consistent with the earlier immunohistochemical identification of parenchymal cells as local production sites in numerous organs of tilapia (Reinecke et al. 1997 ) and indicate paracrine/autocrine actions of local IGF-I involved in organ-specific functions of adult bony fish.
Some studies in bony fish showing the presence of IGF-I and its receptor (IGF-1R) in fish embryos suggest a high organizational impact of IGF-I during ontogeny. Developmental and tissue-specific regulation of the steady-state mRNA levels of IGF-1R and polyadenylation have been detected in rainbow trout and seabream (Perrot et al. 1999) . Correspondingly, some RT-PCR studies on trout (Shamblott and Chen 1993; Duan et al. 1995; Chen 1997, 1999) , seabream (Duguay et al. 1996; Perrot et al. 1999 ) and rabbitfish (Ayson et al. 2002) suggest that the expression patterns of IGF-I mRNA in several organs are also age-dependent. The physiological importance of IGF-I in early fish development is further underlined by the demonstration of the marked mitogenic effects of IGF-I on zebrafish embryonic cells (Pozios et al. 2001) .
However, little information exists regarding the cellular sites of IGF-I synthesis, with only two studies in seabream (Perrot et al. 1999 ) and rabbitfish (Radaelli et al. 2003) and some preliminary data in tilapia (Shved et al. 2005) reporting the localization of IGF-I during ontogeny. These reports involve the investigation of several organs at different larval stages by the use of immunohistochemistry. However, no thorough study on the cellular IGF-I production during early fish development has been performed and no other species have been examined. Furthermore, to date, in situ hybridization has not been used to detect the cellular expression of IGF-I mRNA during ontogeny. Therefore, we have investigated the potential production sites of IGF-I in numerous organs, such as liver, gastro-intestinal tract, exo-and endocrine pancreas, kidney, skeletal muscle, cartilage, gills, skin, brain and pituitary, in early developmental stages, i.e. from 0 day post fertilization (DPF) to 140 DPF, of tilapia (Oreochromis niloticus) and in adult individuals. We have used immunohistochemistry to localize IGF-I peptide and in situ hybridization to detect the expression of IGF-I mRNA.
Materials and methods

Animals
The fry and adult Oreochromis niloticus used in this study originated from the Aquaculture Experimental Facilities of CIRAD (Montpellier). Fertilized eggs were obtained through either natural or artificial fertilization. For natural fertilization, 0. niloticus breeders (1 male and 3 females) were maintained in a spawning aquarium of 360 l maintained at constant temperature (27°C) and photoperiod (12L:12D). Under natural photoperiods, reproductive activity occurs mainly from the afternoon until sunset in these species (Baroiller et al. 1997) . Consequently, we checked every morning for the presence of newly incubating females, which were then isolated from the other fish. On the first day after fertilization, eggs were gently removed from the mouth of the female and incubated in 1-l McDonald jars at 27±1°C (mean range). For artificial fertilization, the maturation of isolated females was carefully recorded (i.e. uro-genital papilla development and behaviour). When the near-breeding stage was reached, both male and female breeders were striped under anaesthesia. Fertilization was performed according to Chourrout and Itskovitch (1983) . After fertilization, eggs were incubated in 1-l McDonald jars, maintained at 27°C, to the free-swimming stage (around 10 DPF). Just before the completion of yolk sac absorption, fry were placed into a 50-l tank in an indoor recirculating system at 27±1°C. They were fed with commercial salmonid food.
Fish larvae at various developmental stages, i.e. from 0-140 DPF, and adults were sampled and anaesthetized by the addition of 2-phenoxy-ethanol (Sigma, St. Louis, Mo., USA) to water (0.3 ml/l). For the earliest stages, the trunk was cut to allow fixation solution to enter. If the larvae had reached a sufficient size, the organs were excised. Tissue preparations were fixed with Bouin's solution without acetic acid for 4 h at room temperature. Specimens were dehydrated in an ascending series of ethanol and routinely embedded in Paraplast (58°C).
Generation of tilapia-specific probes for in situ hybridization
The probes used were prepared as previously described (Schmid et al. 1999) . In brief, total RNA from tilapia liver was extracted by the phenol/chloroform method with an Ultraspec Extraction Kit (ams, Lugano, Switzerland). For cDNA synthesis, 5 μg RNA were annealed with 1 μM poly (dT) primer (5′-CC TGAATTCTAGAGCTCAT(dT17)-3′) for 3 min at 70°C. The RNA/primer mix was incubated for 1 h at 37°C with 15 mM dNTPs and 10 U AMV-reverse transcriptase (Pharmacia, Switzerland) in 1× reaction buffer (50 mM TRIS-HCl pH 8.3, 40 mM KCl, 6 mM MgCl 2 ). A 1-μl cDNA aliquot was incubated with 1 μM of the sense (5′-GTCTGTGGAGAGCGAGGCTTT-3′) and antisense primer (5′-AACCTTGGGTGCTCTTGGCATG-3′), corresponding to the B-and E-domains (Reinecke et al. 1997) , 200 μM dNTPs, and 1 U Taq-polymerase (Pharmacia) in 1× incubation buffer (10 mM TRIS-HCl pH 8, 50 mM KCl, 1.5 mM MgCl 2 , 0.001% gelatine). The amplification program was optimized for a Stratagene RoboCycler Gradient 40 as follows: one cycle of 10 min at 94°C, 1 min at 59°C, 2 min at 72°C; 30 cycles of 1 min at 94°C, 1 min at 59°C and 2 min at 72°C followed by a final extension step of 5 min at 72°C. PCR fragments were separated on a 2% agarose gel and eluted by Gel Extraction Kit QIAquick (Qiagen, Switzerland). PCR products were cloned in a pCR-Script SK(+) cloning vector (Stratagene, Heidelberg, Germany). After propagation of Escherichia coli containing the plasmids, purification of the plasmids was performed with the Midi Purification Kit (Qiagen). Plasmids with the IGF-I fragment were sequenced (Microsynth, Switzerland) and the sequences were compared with those in a database. The plasmids containing the specific inserts of IGF-I (207 bp) were used as templates for the synthesis of the digoxigenin (DIG)-labelled RNA probes. Linearization was performed with the restriction enzyme EcoRI for T3 polymerase-driven transcription and with NotI for T7 polymerase-driven transcription. After ethanol precipitation, linearization efficiency was assured on a 1.2% agarose gel. The linearized plasmids (1 μg) were transcribed in vitro by using a transcription kit (Roche Diagnostics, Germany) in the presence of DIG-UTP to obtain the antisense and sense probes. The IGF-I probes selectively detected tilapia IGF-I and not tilapia IGF-II, as shown previously (Schmid et al. 1999) . The integrity of the probes and the efficiency of the labelling were confirmed by gel electrophoresis, including blotting and incubation with antibody (Ab), and by dot blot. For dot blot, 1 μl various dilutions (undiluted, 1:10, 1:100, 1:1,000) of probes and control RNAs were dropped onto a nylon membrane (Roche Diagnostics) and fixed by UV crosslinking (254 nm, 125 mJ). The membrane was washed with 1% blocking reagent (Roche-Diagnostics) in buffer P1 for 30 min followed by treatment with alkaline phosphatase (AP)-coupled anti-DIG Ab (Roche Diagnostics) diluted at 1:2,000 with 1% blocking reagent in P1 for 30 min. After a rinse with P1, the membrane was equilibrated with buffer P3 and finally washed with 1:50 diluted nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP) stock solution (Roche Diagnostics) until colour development. For gel electrophoresis and blotting, probes (200 ng) were loaded onto a 1% denaturing formaldehyde agarose gel in 1× MOPS and run at 80 V for 1.5 h. After the run, gel and membrane were shaken in diethylpyrocarbonate (DEPC)-H 2 0 for 5 min. Capillary transfer was carried out with 20× standard sodium citrate (SSC) overnight. Nucleic acids were fixed by UV-crosslinking. Subsequently, the membrane was incubated with the AP-labelled anti-DIG Ab by applying the same procedure as for dot blot. Lengths of the probes were compared with control RNA (760 nt, Roche Diagnostics).
In situ hybridization protocol Sections (4 μm thick) were mounted on Super Frost Plus slides (Menzel-Gläser, Germany) and dried overnight at 42°C. After being dewaxed and rehydrated, the sections were fixed with 4% paraformaldehyde and 0.1% glutaraldehyde in 1× phosphate-buffered saline (PBS). The following steps were carried out with DEPC-treated solutions in a humified chamber. The sections were digested with 0.02% proteinase K in 20 mM TRIS-HCl -none, +/-very few, + some, ++ moderate, +++ majority, ++++ overall pH 7.4, 2 mM CaCl 2 for 10 min at 37°, treated with 1.5% triethanolamine and 0.25% acetic anhydride for 10 min at room temperature and incubated with 50 μl prehybridization solution per section for 3-4 h at 54°C. Hybridization was carried out overnight at 54°C with 30 μl of hybridization buffer containing 10 ng sense or antisense probe previously denaturated for 5 min at 85°C. Slides were washed for 15 min at room temperature in 2× SSC and for 30 min at the specific hybridization temperature at descending concentrations of SSC (2×, 1×, 0,5×, 0,2×). The anti-DIG AP-coupled Ab was diluted 1:4,000 in 1% blocking reagent (Roche-Diagnostics) in buffer P1 and applied to the sections for 1 h at room temperature in the dark. After being washed twice in P1 for 15 min, the sections were treated with buffer P3, 5 mM levamisole and NBT/BCIP stock solution (Roche Diagnostics). Colour development was carried out overnight at room temperature and stopped by rinsing in tap water for 15 min.
Immunohistochemistry
Sections were cut at 4 μm, mounted onto glass slides (Menzel-Gläser) and dried overnight at 42°C. After being dewaxed and rehydrated, they were used for immunohistochemistry. To reduce unspecific binding, sections were treated with PBS (pH 7.4) containing 2% bovine serum albumin for 30 min at room temperature. Thereafter, the sections were incubated overnight with rabbit antiserum 116 raised against human IGF-I (Reinecke et al. 1997; Schmid et al. 1999 ) diluted at 1:400 and washed repetitively in PBS. The IGF-I antiserum was detected by incubation with biotinylated goat anti-rabbit IgG (Bioscience Products, Emmenbrücke, Switzerland; 1:100) for 30 min at room temperature. After repetitive rinses in PBS, the sections were incubated with streptavidin-fluoresceinisothiocyanate (Bioscience Products; 1:100) for 30 min at room temperature in the dark. The specificity of the reactions obtained was tested by using the following controls: (1) replacement of the primary antiserum by nonimmune rabbit serum, (2) pre-absorption of the primary antiserum with recombinant human (h) IGF-I, hIGF-II, porcine insulin (kind gift of Prof. J. Zapf, Zürich) or the peptide used for immunization (40 μg or 400 μg peptide/ml diluted antiserum). Photomicroscopy was performed with a Zeiss Axioscope and Axiovision software 3.1. (Zeiss, Zürich, Switzerland).
Results
General
During early development, IGF-I mRNA and peptide were observed in all organs investigated. However, the onset of IGF-I expression and its duration differed considerably among the various tissues and organs (Table 1) . 
Liver
At 4 DPF, several hepatocytes started to exbibit IGF-I mRNA followed by IGF-I immunoreactivity around 6-7 DPF (Table 1) . By 12 DPF, numerous hepatocytes showed IGF-I mRNA and some also contained IGF-I peptide (Fig. 1a,b) . Around 36 DPF, a larger number of hepatocytes contained IGF-I mRNA ( Fig. 1d ) and about half of the hepatocytes also possessed IGF-I immunoreactivity at variable intensity (Fig. 1c) . Whereas the expression of IGF-I mRNA persisted in hepatocytes, the presence of IGF-I peptide decreased with age and could not be detected after 90 DPF.
Gastro-intestinal tract IGF-I mRNA and peptide appeared in cells of the intestinal mucosal epithelium at 5 DPF (Fig. 2a,b) . At 9 DPF, they were also detected in cells of the stomach epithelium.
Virtually all epithelial cells of the gastro-intestinal tract contained IGF-I mRNA and peptide. IGF-I-immunoreactive material was mainly located in the cell apex ( Fig. 2a,c,d ). The largest numbers of mucosal epithelial cells exhibiting IGF-I mRNA and peptide were found at 13-29 DPF (Fig. 2c -e, Table 1 ). Around 17 DPF, additional IGF-I-containing cells were detected with the typical appearance of endocrine cells (Fig. 2c ). These IGF-Iimmunoreactive cells occurred in all portions of the gastrointestinal tract but their distribution and frequency varied largely among different individuals. The cells persisted until the adult stage, whereas the presence of IGF-I immunoreactivity in the cell apex was limited to about 50 DPF (Table 1) .
Pancreas
In the exocrine pancreas, the first cells with IGF-I mRNA were present as early as 4 DPF. Their number increased at around 6 DPF ( Fig. 2f ) and persisted at a high level until 18 DPF (Table 1) . Thereafter, the number of IGF-I-containing acinar cells decreased until about 90 DPF and could not be detected in adults. At 6 DPF, some islet cells appeared containing IGF-I mRNA (Fig. 2f ) and peptide. Their number increased until 18 DPF. The IGF-I-containing islets cells did not contain insulin (Fig. 2g,h ).
Kidney
At 8 DPF, IGF-I immunoreactivity (Fig. 3a) and mRNA appeared in the vast majority of renal vesicles and in the pronephric ducts. Faint IGF-I immunoreactivity (Fig. 3b) and mRNA were present in the renal tubules forming around 13 DPF. In the pronephric ducts, IGF-I immunoreactivity was located in the apical cell portion (Fig. 3a,b) . Around 17 DPF, the epithelial cells of the pronephric urinary ducts (Fig. 3c ) contained strong IGF-I immunoreactivity in the cell apex. Furthermore, numerous proximal tubules exhibited IGF-I mRNA (Fig. 3d) and immunoreactivity (Fig. 3e) , whereas most of the distal tubules showed only faint reactions (Fig. 3e) . This distribution pattern persisted until 25 DPF (Fig. 3f) . Later, some proximal and distal tubules contained IGF-I immunoreactivity ( Fig. 3g ) and mRNA. In addition, strong IGF immunoreactivity was present in the apical cell portions of the collecting ducts (Fig. 3g) . The same distribution pattern was also found in juvenile and adult tilapia (Table 1) .
Cartilage
Even at 4-5 DPF, IGF-I mRNA and peptide were present in cartilage ( Table 1 ). The expression of IGF-I was most pronounced in growing regions (Fig. 4a,b) . Numerous chondrocytes expressing IGF-I were found in the cartilage (Figs. 4c,d,g, 5a, 6a,d ) throughout development. Their number slowly decreased with time and they were also found in adult life.
IGF-I was also detected by in situ hybridization and immunohistochemistry in the perichondrium starting at 4 DPF. The expression of IGF-I in the perichondrium was most pronounced between 6 and 50 DPF (Table 1) and persisted throughout life at a moderate level.
Muscle IGF-I mRNA and peptide appeared in skeletal muscle fibers at 4 DPF ( Table 1) . Both were present in the cytoplasm (Fig. 4e,f) . The highest expression of IGF-I in skeletal muscle was between 8 and 29 DPF (Table 1) . Thereafter, it decreased ( Fig. 4g ) but persisted throughout development and adult life.
Gills
The production of IGF-I in gills had its onset at 6 DPF ( Fig. 5a ; Table 1 ). From the beginning, both IGF-I mRNA and peptide occurred in the majority of chloride cells. This distribution pattern was found throughout development (Fig. 5b,c) and adult life.
Heart
At 13 DPF, IGF-I was first detected in the developing heart (Table 1) . IGF-I was present both in atrial (Fig. 5d) and ventricular (Fig. 5e ) myocardiocytes. The highest amount of IGF-I-containing myocardiocytes was present from 19 to 29 DPF. In general, the number of cells showing IGF-I mRNA was higher than that of cells exhibiting IGF-I immunoreactivity (Table 1) . During late development and in adults, no IGF-I could be detected in the heart. Brain In brain, strong IGF-I mRNA signals were revealed in numerous neurones of the brain of larvae (Fig. 6a) starting around 6 DPF (Table 1) . Similarly, IGF-I immunoreactivity was present in the vast majority of neurones (Fig. 6c) . In addition, IGF-I was expressed in spinal (Fig. 6d) and in developing autonomic ganglia. This overall neuronal presence of IGF-I persisted until about 29 DPF and slowly decreased thereafter. In older larvae and adult individuals, IGF-I mRNA and peptide, although still found at all levels of brain and spinal cord, were present in some neurones only. In the older fish, the number of neurones containing IGF-I mRNA exceeded that of the IGF-I-immunoreactive neurones. Whereas in most areas of the brain, the distribution patterns of IGF-I mRNA and peptide varied largely among the individuals investigated, the Purkinje cells in the cerebellum always showed IGF-I peptide (Fig. 6e) and mRNA (Fig. 6f) . Starting at 4 DPF, IGF-I immunoreactivity and mRNA were observed in the meninges (Fig. 6a) . The expression of IGF-I persisted at the initial level until 50 DPF but stayed at a low level throughout life (Table 1) . (Fig. 7a,c ) appeared in the posterior (neuro-) pituitary around 17 DPF (Table 1) . Their density decreased with age but they were still detected in adults. No IGF-I mRNA was detected in the posterior pituitary. IGF-I-immunoreactive neurons occurred in hypothalamus (Fig. 7c) . Endocrine cells of the anterior (adeno-) pituitary first exhibited IGF-I mRNA at 28 DPF (Fig. 7b) followed by IGF-I immunoreactivity at 40 DPF (Fig. 7c) . IGF-I immunoreactivity (Fig. 7c) and mRNA (Fig. 7d ) in endocrine cells were present throughout development and in adults.
Skin
At 5 DPF, IGF-I immunoreactivity appeared in cells of the epidermis (Fig. 8a) . First, the number of epidermal cells exhibiting IGF peptide (Fig. 8b) and mRNA ( Fig. 8c) increased with age to reach the highest level around 19-29 DPF (Table 1 ). In older larvae (Fig. 8d,e) and adults, some superficial epidermal cells (arrows) and occasionally also cells in the basal epidermis (arrowhead) were IGF-Iimmunoreactive or contained IGF-I mRNA (Fig. 8e) .
Discussion
This study has revealed the appearance and distribution of IGF-I mRNA and peptide during the early development of the tilapia, O. niloticus. Both IGF-I mRNA and peptide have been observed in parenchymal cells of all organs investigated but the onset, intensity and duration of IGF-I expression differs considerably among the various tissues and organs.
Both IGF-I mRNA and peptide appear in liver at 4 DPF. This early onset of IGF-I production in tilapia liver is in agreement with results obtained in shi drum in which IGF-I immunoreactivity has been detected in hepatocytes during the first week post hatching (Radaelli et al. 2003) . Because liver is the main source of endocrine IGF-I, these results suggest a particular physiological impact of circulating IGF-I in early development. Although high expression of IGF-I mRNA has been detected throughout life in tilapia liver, IGF-I immunoreactivity decreases with age and is present only until about 70 DPF. In contrast to an earlier study on sea bream (Funkenstein et al. 1997) , an intense response by in situ hybridization for IGF-I has been obtained in adult tilapia liver. In spite of the clear expression of IGF-I mRNA in adult tilapia liver (Schmid et al. 1999) , no IGF-I-immunoreactive hepatocytes have been identified in adult barramundi (Richardson et al. 1995) and tilapia (Reinecke et al. 1997; Schmid et al. 1999) . Similarly, in rat liver, IGF-I immunoreactivity has been localized only after pretreatment with colchicine (Hansson et al. 1988 ). Therefore, IGF-I might be released from fish liver into the circulation immediately after synthesis, as has previously been presumed in mammals (Hansson et al. 1988) .
High-affinity hepatic-binding sites for growth hormone (GH) have been identified in the liver of several fish species, including tilapia (Ng et al. 1992 ). In accordance, there is strong evidence that GH stimulates IGF-I expression in fish liver and its secretion into the circulation (see Reinecke et al. 2005) . Injection or oral administration of GH significantly enhances the IGF-I mRNA level in the liver of numerous species (e.g. Duan et al. 1993; Duguay et al. 1994 Duguay et al. , 1996 Moriyama 1995; Shamblott et al. 1995; Shepherd et al. 1997; Vong et al. 2003; Biga et al. 2004 ). The GH-induced increase in liver IGF-I mRNA expression is accompanied by an increase in the level of circulating IGF-I (Funkenstein et al. 1989; Niu et al. 1993; Moriyama et al. 2000) . In addition to these in vivo studies, some in vitro investigations have also demonstrated the stimulating effect of GH on liver IGF-I mRNA expression, i.e. on primary cultured hepatocytes of salmonids Shamblott et al. 1995; Pierce et al. 2005 ) and tilapia . In rainbow trout, GH mRNA has been detected in early stage embryos (Yang et al. 1999 ). Thus, the production and release of liver IGF-I during tilapia early development may be under the control of GH.
The early onset of the production of IGF-I in tilapia gastro-intestinal tract, i.e. at 5 DPF in intestine and at 9 DPF in stomach, supports the results of earlier studies. In the intestinal epithelium of turbot (Berwert et al. 1995) and shi drum (Radaelli et al. 2003) , the first IGF-I-immunoreactive cells can be found as early as the first week post hatching. Furthermore, IGF-1R appears in the second week post hatching in shi drum gut (Radaelli et al. 2003) . The number of IGF-I-producing cells in the developing bony fish gastro-intestinal tract by far exceeds that in the adult because, during ontogeny, almost all epithelial cells throughout the gastro-intestinal tract exhibit IGF-I mRNA and peptide. The IGF-I-immunoreactive material is mainly located in the cell apex as has also been reported in shi drum (Radaelli et al. 2003) , possibly suggesting release into the lumen. Around 17 DPF, additional infrequent IGF-I-containing cells appear in the mucosal epithelium; these cells have the typical appearance of endocrine cells as characterized for adult fish (Reinecke et al. 1997; Koppang et al. 1998) . The distribution of these IGF-I-immunoreactive cells in the various portions of the adult gastro-intestinal tract and their frequency vary largely among different individuals, as previously reported in turbot (Berwert et al. 1995) and Atlantic salmon (Koppang et al. 1998) .
Although the early and overall appearance of IGF-I and its receptor strongly suggests a particular physiological impact of IGF-I in the developing gastro-intestinal tract, we can only hypothesize on the physiological meaning of intestinal IGF-I in fish. IGF-I secreted from the IGF-Iimmunoreactive epithelial cells may exert mitogenic functions by acting on neighbouring epithelial cells. This hypothesis is supported by results obtained in mammals. In pig, the amounts of intestinal IGF-I immunoreactivity and of the IGF-1R can be correlated with villous growth and maturation (Schober et al. 1990 ) and, in adult rat, IGF-I potently stimulates crypt cell proliferation and villus cell density (Steeb et al. 1994) . The potential proliferative action of intestinal IGF-I during development and adult life may be regulated by GH, which markedly increases the amount of intestinal IGF-I mRNA in juvenile common carp (Vong et al. 2003) and adult rainbow trout (Biga et al. 2004) .
In juvenile and adult bony fish, IGF-I released from the infrequent IGF-I-immunoreactive mucosal epithelial cells may exert paracrine effects in response to altering local demands, such as repair. In agreement with this hypothesis, the therapeutical potential of IGF-I has been discerned for numerous acute human bowel disorders resulting in accelerated intestinal repair and epithelial regrowth (Howarth 2003) . Because, in addition to gill and kidney, the intestinal tract exerts important osmoregulatory functions in fish, intestinal IGF-I may also be involved in osmoregulation (Koppang et al. 1998; Reinecke and Collet 1998) . This hypothesis is supported by experiments in brown trout suggesting that IGF-I plays a role in the regulation of intestinal Na + ,K + -ATPase activity .
IGF-I immunoreactivity has been localized in cells of the exocrine parenchyma of shi drum and seabream larvae (Funkenstein et al. 1997; Perrot et al. 1999; Radaelli et al. 2003) ; this is supported by the results of the present study. As IGF-I production in pancreas is stimulated by GH in rat (Jevdjovic et al. 2004 ), IGF-I in fish pancreas may also be under the control of GH, although no results have been presented to date on the potential regulation of IGF-I in the exocrine pancreas.
To date, indications for the presence of IGF-I in the endocrine pancreas have only been obtained by immunohistochemical studies. These have shown that IGF-I immunoreactivity occurs in islet cells of several bony fish species (Reinecke et al. 1993 (Reinecke et al. , 1997 Berwert et al. 1995; Richardson et al. 1995) . The present study provides the additional information that IGF-I mRNA is also present in islet cells. This is supported by molecular biological studies that have shown IGF-I mRNA expression in principal islets of the salmon O. gorbusha ) and of Cottus scorpius (LoffingCueni et al. 1998) . Islet IGF-I appears at 6 DPF in tilapia (this study) and day 10 post hatching in turbot (Berwert et al. 1995) suggesting a significant physiological role for islet-derived IGF-I during larval development. In both species, from the onset of its expression, IGF-I occurs in non-insulin cells. This observation is in agreement with studies on adult teleosts, such as eel, tilapia, goldfish, turbot and common carp (Reinecke et al. 1993 (Reinecke et al. , 1997 Berwert et al. 1995) .
On the one hand, islet-derived IGF-I may be involved in the paracrine regulation of insulin secretion from the β-cells, although the evidence in mammals is conflicting (Leahy and Vandekerkhove 1990; Van Schravendijk et al. 1990; Jevdjovic et al. 2004 ). On the other hand, some studies suggest that islet-derived IGF-I may act as an endocrine hormone. Hypophysectomy does not influence the amount of sulphation activity in eel pancreas (Duan and Hirano 1992) suggesting that islet IGF-I is not regulated by GH. In goby, islectomy leads to a decrease in 35 SO 4 -incorporation in cartilage (Bern et al. 1991) but hepatic GH binding is unchanged (Kelley et al. 1993 ). The observed effects may have been augmented by insulin (Plisetskaya 1998) . However, in addition to the GHdependent liver IGF-I system, islet-derived IGF-I may constitute a further endocrine GH-independent IGF-I system involved in the regulation of fish growth.
No information is available on IGF-I in developing fish kidney. In adult bony fish, however, epithelial cells mainly of the proximal tubules have been reported as sites of IGF-I production in tilapia (Reinecke et al. 1997) , as has similarly been described in adult mammals (see Reinecke and Collet 1998) . In tilapia, IGF-I occurs in renal vesicles even at early stages of development, i.e. at 5 DPF. Later, it is present in proximal and distal tubles and in collecting and urinary ducts. Whereas IGF-I in the tubular sytem is detected throughout the cytoplasm, it occurs only in the apical cell part in the ducts possibly suggesting the release of IGF-I into the lumen. Apart from the gills, the kidney is a major osmoregulatory organ in fish but the evidence for the potential participation of renal IGF-I in osmoregulation is conflicting. In rainbow trout, transfer to seawater has been reported to increase the IGF-I mRNA level in kidney (Sakamoto and Hirano 1993) . In contrast, the same treatment does not affect the Na + ,K + -ATPase gene level and activity in brown trout (Madsen et al. 1995) or the renal IGF-I mRNA level in the four-spine sculpin, Cottus kazika (Inoue et al. 2003) . Thus, at present, we can only speculate about the physiological role of IGF-I in bony fish kidney. In addition to its possible role in osmoregulation, renal IGF-I may be involved in several other parameters of kidney function, such as the stimulation of kidney growth and differentiation, renal blood flow, glomerular filtration rate and sodium absorption, as is likely in mammals (Hirschberg 1996) .
In O. niloticus, IGF-I also appears early in tissues that are highly involved in growth, such as cartilage and skeletal muscle. At 4 DPF, IGF-I mRNA and peptide are present in the chondrocytes of cartilage at various locations. Similarly, in shi drum, IGF-I immunoreactivity has been observed in cartilage at day 11 post hatching (Radaelli et al. 2003) . The expression of IGF-I in tilapia is most pronounced in growing regions. The number of IGF-I-containing chondrocytes is higher during development than in adult life, thus underlining the physiological impact of local IGF-I during cartilage growth. Although the GH/liver IGF-I axis is involved in the regulation of fish growth as an endocrine system (Duan 1998; Reinecke et al. 2005) , an influence of GH on growth via local auto/ paracrine IGF-I, as indicated by the present results, is also likely. An early study on eel has determined that the stimulatory effect of GH on sulphate incorporation into cartilage is mediated by an IGF-like plasma factor (Duan and Inui 1990) . In agreement, the injection of GH into coho salmon cartilage stimulates sulphate and thymidine incorporation (McCormick et al. 1992; Tsai et al. 1994 ). Thus, GH may have increased both uptakes via the stimulation of local IGF-I, because IGF-I peptide and mRNA have been shown in chondrocytes of developing (Perrot et al. 1999; Radaelli et al. 2003 ; this study) and adult (Funkenstein et al. 1997; Reinecke et al. 1997 ) bony fish. The GH-dependent growth promoting effects of IGF-I on cartilage may therefore be exerted not only via the endocrine route, but also in an autocrine/paracrine manner by IGF-I released from local chondrocytes, as has been shown in rat .
In contrast to the skeletal muscle of young shi drum larvae (Radaelli et al. 2003) in which no IGF-I immunoreactivity has been detected, the onset of IGF-I production in tilapia skeletal muscle occurs at 4 DPF, with IGF-I showing a maximum around 10-29 DPF, decreasing afterwards but persisting throughout life. In agreement with an auto/paracrine function of muscle IGF-I, IGF-I receptor number and binding in trout skeletal muscle are highest at 5 weeks and both parameters decrease with age (Mendez et al. 2001 ). Furthermore, a parallel age-related decline has been found for tyrosine kinase activity for IGF-1R (Mendez et al. 2001) . In rainbow trout muscle in vitro, IGF-I has been shown to be highly effective in stimulating glucose and alanine uptake into myosatellite cells, whereby the degree of stimulation changes when cells differentiate to myotubes (Castillo et al. 2004 ). These and the present results showing that IGF-I in skeletal muscle appears as early as 4 DPF and decreases with age indicate a key role for IGF-I in muscle development. IGF-I may be associated in later life with metabolism and repair mechanisms. In adult rainbow trout, the expression of IGF-I in skeletal muscle is stimulated by GH (Biga et al. 2005) . Thus, GH may also regulate IGF-I production in larval musle.
Endocrine (liver-derived) IGF-I seems to have a physiological impact in smoltification. In mummichog (Fundulus heteroclitus; Mancera and McCormick 1998) and trout , IGF-I improves adaptation to seawater in a dose-dependent manner. The osmoregulatory effects of IGF-I seem to be exerted directly because, in preparations of Coho salmon gills in vitro, IGF-I stimulates Na + ,K + -ATPase (Madsen and Bern 1993) . Hypophysectomy in tilapia lowers the levels of gill Na + , K + -ATPase when compared with that of sham-operated controls (Shepherd et al. 1997) indicating an involvement of the GH/liver IGF-I axis. In agreement, in a study on Cottus kazika, the level of liver IGF-I mRNA has been shown to be significantly higher in individuals reared in seawater than in those reared in freshwater (Inoue et al. 2003) . In sharp contrast, a study on Coho salmon has demonstrated that IGF-I mRNA is not significantly altered during seawater adaptation in liver but markedly increases in gills (Sakamoto and Hirano 1993) . The chloride cells of filament epithelium have been shown not only to express Na + ,K + -ATPase in trout (McCormick 1996) , but also IGF-I in tilapia (this study), in shi drum larvae (Radaelli et al. 2003) and in adult tilapia (Reinecke et al. 1997) . GH receptors have been detected in tilapia gills (Fryer 1979) and GH treatment increases IGF-I mRNA in gills of salmonids and carp (Vong et al. 2003; Biga et al. 2004 ). Thus, in addition to circulating IGF-I, GH-regulated local autocrine/paracrine IGF-I in the chloride cells seems to participate in the regulation of plasma osmolality and gill Na + ,K + -ATPase activity. Because the expression of IGF-I in tilapia gill chloride cells has been detected even around 6-7 DPF, IGF-I may exert additional functions, such as influencing the growth and maintenance of the filament epithelium.
In shi drum heart, IGF-I immunoreactivity has been detected in 15-day larvae (Radaelli et al 2003) . Likewise, IGF-I mRNA and peptide appear at 13 DPF in tilapia. The expression of IGF-I in cardiomyocytes is clearly detectable until 70 DPF but is absent from later stages and adults indicating a particular physiological impact of IGF-I during heart development and growth. In correlation, a significant increase in IGF-1R mRNA levels (Gutiérrez et al. 1995) has been observed in the rapidly growing juvenile trout heart . In fish heart, local IGF-I may be even more important than circulating IGF-I. In rainbow trout heart IGF-1R mRNA levels decrease after application of GH (Biga et al. 2004 ) and the number of IGF-I receptors is inversely related to the concentration of circulating IGF-I (Baños et al. 1997; Moon et al. 1996) .
Screening studies have identified the potential sites of IGF-I synthesis in the brains of barramundi, tilapia and sea bream. IGF-I-immunoreactive neurones are present in adult barramundi brainstem (Richardson et al. 1995) and at all levels of adult tilapia brain (Reinecke et al. 1997 ). Correspondingly, IGF-I mRNA signals have been described throughout the brain of developing sea bream (Funkenstein et al. 1997) . The functional impact of IGF-I in brain is indicated by the presence of IGF-1R in adult carp and trout brain (Leibush et al. 1996) and by the appearance of IGF-1R immunoreactivity in the developing brain of shi drum as early as hatching (Radaelli et al. 2003) . In contrast to IGF-II (Caelers et al. 2003) , the exact distribution of IGF-I gene expression in fish brain is unknown. The IGF-Iimmunoreactive neurones in barramundi and tilapia are sparsely scattered and their distribution exhibits pronounced inter-individual differences. In juvenile (this study) and adult tilapia (Reinecke et al. 1997 ) and adult daddy sculpin (Loffing-Cueni et al. 1998) brain, only IGF-I-producing Purkinje cells in cerebellum are constantly present. In agreement with the potential autocrine/paracrine action of neuronal IGF-I in adult brown trout, Salmo trutta, IGF-I binding in the brain is highest in the cerebellum (Smith et al. 2005) . The pronounced inter-individual variations of IGF-I-producing neurones in adult fish brain make a neurotransmitter or -modulator function of IGF-I unlikely. Rather, neuronal IGF-I may support the survival of neurones and glia cells, as is also likely for mammals (Cheng et al. 2001) . During development, IGF-I may stimulate neurogenesis, dendritic growth and synaptogenesis in an autocrine/paracrine manner, as has been shown in mammals (e.g. Zhou et al. 1999; Niblock et al. 2000; Kakizawa et al. 2003) . This hypothesis is supported by the observation that, in early developing tilapia larvae, most neurones express IGF-I mRNA and that the number of neurones containing IGF-I mRNA decreases with age. Whether the assumed actions of IGF-I are exerted under the control of GH is unclear at present, since GH significantly increases brain IGF-I mRNA in rainbow trout (Biga et al. 2004) , whereas no effect has been reported in common carp (Vong et al. 2003) .
The present study is the first to show that IGF-I occurs in the bony fish pituitary. IGF-I has been observed in both the neuro-and adenopituitary. In the posterior part, neurosecretory axons containing IGF-I immunoreactivity appear around 17 DPF, whereas no IGF-I mRNA is detected at this stage. The likely source of IGF-I in the neuropituitary is the neuronal perikarya that lie within the hypothalamus and that exhibit IGF-I immunoreactivity. In the adenopituitary, IGF-I mRNA is first detected at 20 DPF. IGF-I immunoreactivity and mRNA in endocrine cells are present throughout development. To date, IGF-I immunoreactivity has only been localized in the anterior pituitary in the frog Xenopus laevis in which it occurs in co-existence with prolactin (David et al. 2000) . Because IGF-I-binding sites have also been found in X. laevis anterior pituitary, IGF-I from the prolactin cells has been postulated to regulate GH in a paracrine manner (David et al. 2000) . Whether this hypothesis also applies to bony fish remains to be clarified, as does the type of endocrine cells producing IGF-I.
At 5 DPF, IGF-I has been detected in cells of the epidermis of tilapia. The number of IGF-I-producing epidermal cells first increases with age, reaching its highest level around 19-29 DPF. In older larvae and adults, some superficial and basal epidermal cells exhibit IGF-I immunoreactivity or IGF-I mRNA. In developing skin of shi drum, IGF-1R immunoreactivity is detectable even at hatching (Radaelli et al. 2003) . The early appearance of both IGF-I and its receptor suggests an important auto/ paracrine function of IGF-I in skin development. Because some IGF-I producing cells still occur in the basal and superficial layers in juvenile and adult tilapia and as high levels of IGF receptor mRNA have been found in adult gilthead seabream skin (Perrot et al. 1999) , local IGF-I in fish skin might play a role in later life. Skin IGF-I might be involved in repair mechanisms and wound healing, as has been proposed in mammals (Edmondson et al. 2003) .
In summary, the expression of IGF-I is more pronounced during ontogeny than in juvenile and adult life in the parenchymal cells of most of the organs investigated, such as epithelial cells of the gastro-intestinal tract, acinar cells of the exocrine pancreas, skeletal muscle cells, cardiomyocytes, renal tubular cells, neurones of the central and peripheral nervous system and skin cells. These results suggest a high functional impact of local IGF-I in early fish growth, metabolism and organogenesis by auto/paracrine means of regulation. Whether IGF-I expression in the early development of fish is regulated by GH remains to be clarified (Perrot et al. 1999; Deane et al. 2003) , although low levels of GH mRNA have been detected as early as gastrulation in rainbow trout and intermediate amounts of GH mRNA have been observed in early cleavage-stage embryos (Yang et al. 1999) .
